Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-89.50	61.93	589.93
Graham Fair Price	-47.80	5.54	10.61
PEG	-473.19	-1.27	-0.22
Price/Book	-9.55	2.05	2.27
Price/Cash Flow	1093.25	-743.18	62.28
Prices/Earnings	233.11	92.90	27.89
Price/Sales	-4.97	7.02	7.39
Price/FCF	1093.25	-743.18	62.28
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	3.14	0.53	0.52
Operating Margin	251.76	0.06	0.02
ROA	-72.20	< 0.005	< 0.005
ROE	0.02	< 0.005	-72.85
ROIC	0.00	< 0.005	100.00
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.04	0.08	-53.30
Dividends QOQ	0.04	-0.02	-51.06
EBIT QOQ	1.07	2.31	116.57
EPS QOQ	1.25	-0.73	-41.88
FCF QOQ	0.24	-1.08	353.37
Revenue QOQ	0.07	-0.06	-15.06
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	114.61	123.70	7.93
Days Sales Outstanding (DSO)	67.23	61.95	-7.86
Inventory Turnover	0.79	0.73	-7.35
Debt/Capitalization	0.40	0.39	-1.72
Quick Ratio	0.79	0.71	-9.65
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	15.68	15.71	0.18
Cash	1.75	1.40	-19.71
Capex	-0.19	-0.16	13.93
Free Cash Flow	0.57	-0.04	-92.41
Revenue	4.82	4.59	-4.65
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.38	1.43	3.29
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	122.81	13.81	-88.76
Naive Interpretation	Member

06 - Financial Health · Weak

Rating